Literature DB >> 11589354

Changes in smoking habits and risk of asthma: a longitudinal population based study.

N S Godtfredsen1, P Lange, E Prescott, M Osler, J Vestbo.   

Abstract

A common statement from exsmokers is that symptoms of asthma develop shortly after smoking cessation. This study, therefore, investigated the relationship between smoking cessation and development of asthma in a large cohort from the Copenhagen City Heart Study (CCHS). The CCHS is a longitudinal, epidemiological study of the general population from the capital of Denmark, conducted between 1976 and 1994. The study population involved the 10,200 subjects who provided information on self-reported asthma and smoking habits from the first two examinations (baseline and 5-yr follow-up), and the 6,814 subjects who also attended the third and last examination (10-yr follow-up). The point-prevalence of smoking cessation as well as the asthma incidence between examinations was estimated, and a multivariate logistic regression model was used to examine the relationship between changes in smoking habits and development of asthma. During the study period, asthma incidence increased from 1.2-4.2%. Between examinations 1,316 subjects quit smoking. Smoking cessation between examinations was significantly related to reported asthma at follow-up. With never-smokers as the reference group and following adjustment for sex, age, chronic bronchitis, level of forced expiratory volume in one second and pack-yrs of smoking, the odds ratio (OR) for developing asthma when quitting smoking between examinations was 3.9 (95% confidence interval (CI) 1.8-8.2) from baseline to first follow-up and 3.1 (95% CI 1.9-5.1) from first to second follow-up. Continuing smoking also increased the risk of asthma significantly (OR 2.6 and 2.0, respectively). The results indicate that exsmokers have a higher incidence of self-reported asthma than never-smokers. It is likely that subjects perceive chronic obstructive pulmonary disease as asthma, hence the relationship between smoking cessation and asthma might be due to misclassification rather than causality.

Entities:  

Mesh:

Year:  2001        PMID: 11589354     DOI: 10.1183/09031936.01.00100801

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

1.  Psychological distress and depressed mood in employees with asthma, chronic bronchitis or emphysema: a population-based observational study on prevalence and the relationship with smoking cigarettes.

Authors:  Edwin J Wagena; Ijmert Kant; Marcus J H Huibers; Ludovic G P M van Amelsvoort; Gerard M H Swaen; Emiel F M Wouters; Constant P van Schayck
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

2.  Nicotine primarily suppresses lung Th2 but not goblet cell and muscle cell responses to allergens.

Authors:  Neerad C Mishra; Jules Rir-Sima-Ah; Raymond J Langley; Shashi P Singh; Juan C Peña-Philippides; Takeshi Koga; Seddigheh Razani-Boroujerdi; Julie Hutt; Matthew Campen; K Chul Kim; Yohannes Tesfaigzi; Mohan L Sopori
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

3.  Opposing trends in the prevalence of health professional-diagnosed asthma by sex: a Canadian National Population Health Survey study.

Authors:  S Ghosh; P Pahwa; D Rennie; H H McDuffie
Journal:  Can Respir J       Date:  2008-04       Impact factor: 2.409

Review 4.  Systematic review of the evidence relating FEV1 decline to giving up smoking.

Authors:  Peter N Lee; John S Fry
Journal:  BMC Med       Date:  2010-12-14       Impact factor: 8.775

5.  Smoking, respiratory symptoms and likely asthma in young people: evidence from postal questionnaire surveys in the Wythenshawe Community Asthma Project (WYCAP).

Authors:  Peter Frank; Julie Morris; Michelle Hazell; Mary Linehan; Timothy Frank
Journal:  BMC Pulm Med       Date:  2006-05-22       Impact factor: 3.317

Review 6.  Cholinergic Modulation of Type 2 Immune Responses.

Authors:  Goele Bosmans; Gabriel Shimizu Bassi; Morgane Florens; Erika Gonzalez-Dominguez; Gianluca Matteoli; Guy E Boeckxstaens
Journal:  Front Immunol       Date:  2017-12-19       Impact factor: 7.561

7.  A dynamic nomogram for predicting the risk of asthma: Development and validation in a database study.

Authors:  Lifen Yang; Meihua Li; Qinling Zheng; Chaofeng Ren; Wei Ma; Yanxia Yang
Journal:  J Clin Lab Anal       Date:  2021-06-14       Impact factor: 2.352

8.  Bronchodilatory and anti-inflammatory effects of ASM-024, a nicotinic receptor ligand, developed for the treatment of asthma.

Authors:  Evelyne Israël Assayag; Marie-Josée Beaulieu; Yvon Cormier
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

Review 9.  Smoking cessation strategies for patients with asthma: improving patient outcomes.

Authors:  Jennifer L Perret; Billie Bonevski; Christine F McDonald; Michael J Abramson
Journal:  J Asthma Allergy       Date:  2016-06-24

10.  Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity.

Authors:  Lauriane Galle-Treger; Yuzo Suzuki; Nisheel Patel; Ishwarya Sankaranarayanan; Jennifer L Aron; Hadi Maazi; Lin Chen; Omid Akbari
Journal:  Nat Commun       Date:  2016-10-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.